The IsoPlexis Difference

IsoPlexis is accelerating the fight against our toughest diseases by revealing the true functional biology of every patient cell

About Us2019-10-10T15:08:22-04:00

Our Mission

Highly Personalized Medicine

IsoPlexis is dedicated to accelerating the fight against cancer and a range of our toughest diseases by producing the world’s most precise, award-winning detection systems. By revealing unique immune biomarkers in small subsets of cells, we are advancing immunotherapies and targeted therapies to a more highly precise & personalized stage.

Leadership Team

“We are pleased to lead the financing of IsoPlexis, an emerging leader in single cell analysis, which is catalyzing research in immunotherapy as well as a number of other high-value applications.”

Chris MacGriff of Northpond Ventures

Investors

“IsoPlexis closes $25 million Series C.”

Board of Directors
and Scientific Advisory Board

Distributors

Request a Seminar

Request a Seminar
Discover IsoLight